# Biotech Neo Labs - Buyer List Well-funded AI-for-biology labs that could buy [[Drugverse]] environments, evals and data. Snapshot: Oct 2026. > [!warning] Reported figures > Many rounds come from trackers and press reports. "Talks" means not closed. Verify before outreach. ## Priority targets | Lab | What it does | Money | Why it fits | |---|---|---|---| | **Miles Wang startup** (ex-OpenAI) | AI models for drug repurposing, incl. failed trial drugs | Talks: ~$200M at $2B, Lightspeed lead (Jul 2026, unconfirmed)^[Source: [TechCrunch](https://techcrunch.com/2026/07/14/openai-researcher-miles-wang-in-talks-to-launch-ai-drug-discovery-startup-valued-at-2b/)] | Direct fit with Scope and repurposing tasks | | **OpenAI Rosalind unit** | GPT-Rosalind bio reasoning model (Apr 2026). Bought Orchestra Bio (Oct 2026). Works with Novo Nordisk, Moderna | OpenAI balance sheet^[Source: [Axios](https://www.axios.com/2026/10/20/exclusive-openai-biotech-startup-drug-development)] | Needs bio evals and RL tasks at scale | | **Edison Scientific** (FutureHouse spinout) | Autonomous AI scientist (Kosmos) | $70M seed at ~$250M (Dec 2025)^[Source: [Edison](https://edisonscientific.com/news/we-raised-70m-to-accelerate-science)] | Agents that read literature and query databases | | **Chai Discovery** | Molecular foundation models. OpenAI-backed | $400M Series C at $3.8B (Jul 2026). Deals with Lilly, Pfizer, Novartis, argenx^[Source: [IntuitionLabs](https://intuitionlabs.ai/articles/chai-discovery-series-c-valuation)] | Target and mechanism context for design | ## Wider list | Lab | What it does | Money | |---|---|---| | **Isomorphic Labs** (Alphabet) | AI drug discovery | $2.1B Series B (May 2026). Reported talks at $40–50B^[Source: [Cure tracker](https://wewillcure.com/insights/news/ai-and-machine-learning/ai-drug-discovery-venture-funding-tracker-2026); [Juniper tracker](https://juniper.xyz/ai-neolab-tracker)] | | **Lila Sciences** (Flagship) | "Scientific superintelligence", autonomous labs | ~$550M raised. Talks for ~$2B Series B (Jun 2026)^[Source: [Sacra](https://sacra.com/c/lila-sciences/)] | | **Xaira Therapeutics** | AI drug design | ~$1.3B disclosed^[Source: [OnHealthcare](https://www.onhealthcare.tech/p/the-ai-drug-discovery-capital-stack)] | | **Earendil Labs** | AI biologics | $787M (Q1 2026)^[Source: [Cure tracker](https://wewillcure.com/insights/news/ai-and-machine-learning/ai-drug-discovery-venture-funding-tracker-2026)] | | **Lilly × NVIDIA lab** | AI drug discovery lab | $1B over 5 years^[Source: [Cure tracker](https://wewillcure.com/insights/news/ai-and-machine-learning/ai-drug-discovery-venture-funding-tracker-2026)] | | **Aureka Biotechnologies** | Bio foundation models, lab-in-the-loop | $100M (2026)^[Source: [Cure tracker](https://wewillcure.com/insights/news/ai-and-machine-learning/ai-drug-discovery-venture-funding-tracker-2026)] | | **EvolutionaryScale** | Protein language models (ESM) | $142M seed (2024)^[Source: [IntuitionLabs](https://intuitionlabs.ai/articles/ai-biotech-funding-trends)] | | **Latent Labs** | Programmable biology foundation models | $50M (Feb 2025)^[Source: [VC News Daily](https://vcnewsdaily.com/latent-labs/venture-capital-funding/myxzrcbdrz)] | ## Pitch angle by type - **Reasoning and agent labs** (OpenAI Rosalind, Edison, Wang startup): environments, time-split evals, agent trajectories. - **Molecular design labs** (Chai, Isomorphic, Xaira, Latent): integrated target–disease–mechanism data as context and as eval ground truth. ---- tags: #boat #deeptech links: [[TechBio MoC]] [[Drugverse]] [[Drugverse RL Environments and Data Play]] [[Drug Discovery]]